XenoTech (xenotech.com) is a specialized global CRO that is part of the BioIVT family, assisting pharmaceutical companies and researchers to investigate safety-related properties of novel therapeutics through nonclinical testing.

We offer a comprehensive array of test systems and services to explore a drug candidate’s metabolism and drug-drug interaction (DDI) potential. In vitro specialties include enzyme inhibition and induction, drug transporters, and drug metabolism studies (metabolic stability, interspecies comparative metabolite identification, reaction phenotyping). Through our partners in Japan, we also provide radiolabeling services and in vivo ADME (e.g. QWBA, mass balance) studies. Our extensive product selection equips customers world-wide to perform their own in vitro studies with high quality test systems, including an expansive inventory of plateable and suspension hepatocytes, complementary cell media, subcellular fractions, and more.

In addition to providing critical services and test systems to our customers, we provide many learning resources for the drug development community at large by hosting free seminars and webinars and frequently updating our website’s repository with high-quality content such as posters, publications, and blog posts. By providing these products, services, and resources, XenoTech facilitates development of safer drugs, faster.